Cytofluorimetric platelet analysis

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 1, 2014, Pages 88-98

  Carubbi, Cecilia ^a   Masselli, Elena ^a   Gesi, Marco ^b   Galli, Daniela ^a   Mirandola, Prisco ^a   Vitale, Marco ^a   Gobbi, Giuliana ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

flow cytometry; megakaryocytes; platelet disorders; platelets; thrombosis

Indexed keywords

ARTICLE; BERNARD SOULIER DISEASE; BLOOD ANALYSIS; CYTOFLUOROMETRY; FLOW CYTOMETRY; GLANZMANN DISEASE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNE MEDIATED THROMBOCYTOPENIA; MEDICAL RESEARCH; PATIENT MONITORING; PLATELET ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; STORAGE DISEASE; STORAGE POOL DISEASE; THROMBOCYTE ACTIVATION; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; THROMBOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, HUMAN PLATELET; BLOOD PLATELETS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; PLACENTAL FUNCTION TESTS;

EID: 84893685404     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1363472     Document Type: Article

References (86)

1. Malara A., Balduini A. Blood platelet production and morphology. Thromb Res: 2012; 129 3 241 244
2. Broos K., Feys H. B., De Meyer S. F., Vanhoorelbeke K., Deckmyn H. Platelets at work in primary hemostasis. Blood Rev: 2011; 25 4 155 167
3. McCoy J. P. Jr. Basic principles of flow cytometry. Hematol Oncol Clin North Am: 2002; 16 2 229 243 (Pubitemid 34663650)
4. Favaloro E. J., Lippi G., Franchini M. Contemporary platelet function testing. Clin Chem Lab Med: 2010; 48 5 579 598
5. Hickerson D. H., Bode A. P. Flow cytometry of platelets for clinical analysis. Hematol Oncol Clin North Am: 2002; 16 2 421 454 (Pubitemid 34663657)
6. Shattil S. J., Cunningham M., Hoxie J. A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood: 1987; 70 1 307 315 (Pubitemid 17111279)
7. Michelson A. D., Ellis P. A., Barnard M. R., Matic G. B., Viles A. F., Kestin A. S. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood: 1991; 77 4 770 779
8. Santos M. T., Valles J., Marcus A. J., et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest: 1991; 87 2 571 580
9. Michelson A. D., Barnard M. R., Krueger L. A., Valeri C. R., Furman M. I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation: 2001; 104 13 1533 1537 (Pubitemid 32917347)
10. Shattil S. J., Hoxie J. A., Cunningham M., Brass L. F. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem: 1985; 260 20 11107 11114 (Pubitemid 16253272)
11. Stenberg P. E., McEver R. P., Shuman M. A., Jacques Y. V., Bainton D. F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol: 1985; 101 3 880 886 (Pubitemid 16256841)
12. Nieuwenhuis H. K., van Oosterhout J. J., Rozemuller E., van Iwaarden F., Sixma J. J. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood: 1987; 70 3 838 845 (Pubitemid 18027421)
13. Henn V., Slupsky J. R., Gräfe M., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature: 1998; 391 6667 591 594 (Pubitemid 28157601)
14. Faraday N., Goldschmidt-Clermont P., Dise K., Bray P. F. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med: 1994; 123 5 728 740
15. Gobbi G., Mirandola P., Tazzari P. L., et al. Flow cytometry detection of serotonin content and release in resting and activated platelets. Br J Haematol: 2003; 121 6 892 896 (Pubitemid 36760308)
16. Michelson A. D., Barnard M. R., Hechtman H. B., et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A: 1996; 93 21 11877 11882 (Pubitemid 26347217)
17. Berger G., Hartwell D. W., Wagner D. D. P-Selectin and platelet clearance. Blood: 1998; 92 11 4446 4452 (Pubitemid 28544363)
18. Nishibori M., Cham B., McNicol A., Shalev A., Jain N., Gerrard J. M. The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest: 1993; 91 4 1775 1782 (Pubitemid 23127384)
19. de Gaetano G., Cerletti C., Evangelista V. Recent advances in platelet-polymorphonuclear leukocyte interaction. Haemostasis: 1999; 29 1 41 49 (Pubitemid 29446371)
20. Schwarz U. R., Geiger J., Walter U., Eigenthaler M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost: 1999; 82 3 1145 1152 (Pubitemid 29419734)
21. Langford E. J., Wainwright R. J., Martin J. F. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol: 1996; 16 1 51 55 (Pubitemid 26026931)
22. Ault K. A., Cannon C. P., Mitchell J., et al. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol: 1999; 33 3 634 639
23. Tschoepe D., Schultheiss H. P., Kolarov P., et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation: 1993; 88 1 37 42 (Pubitemid 23195430)
24. Gawaz M., Neumann F. J., Ott I., May A., Rüdiger S., Schömig A. Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis. Coron Artery Dis: 1997; 8 3-4 121 128 (Pubitemid 27281074)
25. Lippi G., Montagnana M., Salvagno G. L., et al. Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates. Int J Cardiol: 2007; 115 1 101 102 (Pubitemid 44873033)
26. Carubbi C., Mirandola P., Mattioli M., et al. Protein kinase C ε expression in platelets from patients with acute myocardial infarction. PLoS ONE: 2012; 7 10 e46409
27. Viallard J. F., Solanilla A., Gauthier B., et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood: 2002; 99 7 2612 2614 (Pubitemid 34525455)
28. Falanga A., Marchetti M., Vignoli A., Balducci D., Barbui T. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol: 2005; 33 5 523 530 (Pubitemid 40592168)
29. Landolfi R., Ciabattoni G., Patrignani P., et al. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood: 1992; 80 8 1965 1971
30. Arellano-Rodrigo E., Alvarez-Larrán A., Reverter J. C., et al. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. Am J Hematol: 2009; 84 2 102 108
31. Scharf R. E. Drugs that affect platelet function. Semin Thromb Hemost: 2012; 38 8 865 883
32. Herbert J. M., Savi P. P2Y12, a new platelet ADP receptor, target of clopidogrel. Semin Vasc Med: 2003; 3 2 113 122
33. Aleil B., Ravanat C., Cazenave J. P., Rochoux G., Heitz A., Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost: 2005; 3 1 85 92 (Pubitemid 41647119)
34. Gurbel P. A., Bliden K. P., Guyer K., et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol: 2005; 46 10 1820 1826 (Pubitemid 41579802)
35. Lippi G., Montagnana M., Danese E., Favaloro E. J., Franchini M. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. Biomarkers Med: 2011; 5 1 63 70
36. Solinas E., Gobbi G., Dangas G., et al. Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes. J Thromb Thrombolysis: 2009; 27 1 36 43
37. Franchini M., Lippi G., Veneri D., Targher G., Zaffanello M., Guidi G. C. Inherited platelet disorders. Clin Chim Acta: 2008; 387 1-2 1 8 (Pubitemid 350050924)
38. Nurden A., Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost: 2011; 9 01 76 91
39. Hayward C. P. Diagnostic evaluation of platelet function disorders. Blood Rev: 2011; 25 4 169 173
40. Harrison P., Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost: 2009; 35 2 150 157
41. Mezzano D., Quiroga T., Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost: 2009; 35 2 242 254
42. Miller C. H. Laboratory diagnosis of genetic platelet function defects. In: Hillyer CD, Shaz BH, Zimring JC, Abshire TC, eds. Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. New York, NY: Elsevier Inc: 2009; 623 626
43. Pai M., Hayward C. P. Diagnostic assessment of platelet disorders: what are the challenges to standardization? Semin Thromb Hemost: 2009; 35 2 131 138
44. Miller J. L. Glycoprotein analysis for the diagnostic evaluation of platelet disorders. Semin Thromb Hemost: 2009; 35 2 224 232
45. Nurden A. T., Freson K., Seligsohn U. Inherited platelet disorders. Haemophilia: 2012; 18 04 154 160
46. Michelson A. D. Flow cytometric analysis of platelet surface glycoproteins: phenotypically distinct subpopulations of platelets in children with chronic myeloid leukemia. J Lab Clin Med: 1987; 110 3 346 354 (Pubitemid 18021159)
47. Franchini M., Favaloro E. J., Lippi G. Glanzmann thrombasthenia: an update. Clin Chim Acta: 2010; 411 1-2 1 6
48. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost: 2003; 1 7 1628 1636
49. Jennings L. K., Ashmun R. A., Wang W. C., Dockter M. E. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry. Blood: 1986; 68 1 173 179 (Pubitemid 16033626)
50. Sharp W. J., Khanduri U. D., Christie B. S. Rapid heterozygote detection in Glanzmann's thrombasthenia. Br J Haematol: 1998; 101 1 66 69 (Pubitemid 28197776)
51. Gobbi G., Sponzilli I., Mirandola P., et al. Efficient platelet delta-granule release induced by [Ca2+]i elevation is modulated by GPIIbIIIa. Int J Mol Med: 2006; 18 2 309 313
52. Sandrock K., Zieger B. Current Strategies in Diagnosis of Inherited Storage Pool Defects. Transfus Med Hemother: 2010; 37 5 248 258
53. Nurden A. T., Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev: 2007; 21 1 21 36 (Pubitemid 46097190)
54. Lorez H. P., Richards J. G., Da Prada M., et al. Storage pool disease: comparative fluorescence microscopical, cytochemical and biochemical studies on amine-storing organelles of human blood platelets. Br J Haematol: 1979; 43 2 297 305 (Pubitemid 10243290)
55. Gordon N., Thom J., Cole C., Baker R. Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol: 1995; 89 1 117 123
56. Maurer-Spurej E., Pittendreigh C., Wu J. K. Diagnosing platelet delta-storage pool disease in children by flow cytometry. Am J Clin Pathol: 2007; 127 4 626 632 (Pubitemid 46587478)
57. Prechel M., Walenga J. M. Heparin-induced thrombocytopenia: an update. Semin Thromb Hemost: 2012; 38 5 483 496
58. Tan C. W., Ward C. M., Morel-Kopp M. C. Evaluating heparin-induced thrombocytopenia: the old and the new. Semin Thromb Hemost: 2012; 38 2 135 143
59. Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost: 2014; 40 1 106 114
60. Tomer A. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol: 1997; 98 3 648 656 (Pubitemid 27386546)
61. Vitale M., Tazzari P., Ricci F., et al. Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia. Cytometry: 2001; 46 5 290 295 (Pubitemid 33055230)
62. Tazzari P. L., Ricci F., Vitale M., et al. Heparin-induced thrombocytopenia: detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry. Transfus Med: 2002; 12 3 193 198 (Pubitemid 34685874)
63. Gobbi G., Mirandola P., Tazzari P. L., et al. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia. Cytometry B Clin Cytom: 2004; 58 1 32 38 (Pubitemid 38332718)
64. Cines D. B., Blanchette V. S. Immune thrombocytopenic purpura. N Engl J Med: 2002; 346 13 995 1008
65. Chong B. H., Ho S. J. Autoimmune thrombocytopenia. J Thromb Haemost: 2005; 3 8 1763 1772 (Pubitemid 41716563)
66. Cines D. B., Bussel J. B., Liebman H. A., Luning Prak E. T. The ITP syndrome: pathogenic and clinical diversity. Blood: 2009; 113 26 6511 6521
67. Newman P. J., Derbes R. S., Aster R. H. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest: 1989; 83 5 1778 1781 (Pubitemid 19124140)
68. Mueller-Eckhardt C., Kiefel V., Grubert A., et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet: 1989; 1 8634 363 366 (Pubitemid 19103082)
69. Slichter S. J. Evidence-based platelet transfusion guidelines. Hematology (Am Soc Hematol Educ Program): 2007; 172 178
70. Vamvakas E. C. Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions. Transfus Med Rev: 1998; 12 4 258 270 (Pubitemid 28492978)
71. Delaflor-Weiss E., Mintz P. D. The evaluation and management of platelet refractoriness and alloimmunization. Transfus Med Rev: 2000; 14 2 180 196 (Pubitemid 30196562)
72. Tomer A., Koziol J., McMillan R. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated autoantibodies against platelet-specific receptors. J Thromb Haemost: 2005; 3 1 74 78 (Pubitemid 41647117)
73. Tomer A. Autoimmune thrombocytopenia: determination of platelet-specific autoantibodies by flow cytometry. Pediatr Blood Cancer: 2006; 47 (5, Suppl) 697 700 (Pubitemid 44360033)
74. Carrick D. M., Norris P. J., Endres R. O., et al. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II. Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion: 2011; 51 10 2092 2101
75. Beligaswatte A., Tsiopelas E., Humphreys I., et al. The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness. Br J Haematol: 2013; 162 3 409 412
76. Heikal N. M., Smock K. J. Laboratory testing for platelet antibodies. Am J Hematol: 2013; 88 9 818 821
77. Lippi G., Plebani M. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med: 2012; 50 8 1281 1285
78. Ryningen A., Apelseth T., Hausken T., Bruserud O. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Platelets: 2006; 17 5 296 302 (Pubitemid 44277695)
79. Kienast J., Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood: 1990; 75 1 116 121 (Pubitemid 20031498)
80. Bonan J. L., Rinder H. M., Smith B. R. Determination of the percentage of thiazole orange (TO)-positive, reticulated platelets using autologous erythrocyte TO fluorescence as an internal standard. Cytometry: 1993; 14 6 690 694 (Pubitemid 23245275)
81. Chavda N., Mackie I. J., Porter J. B., Harrison P., Patterson K., Machin S. J. Rapid flow cytometric quantitation of reticulated platelets in whole blood. Platelets: 1996; 7 4 189 194 (Pubitemid 26379809)
82. Harrison P., Goodall A. H. Message in the platelet-more than just vestigial mRNA! Platelets: 2008; 19 6 395 404
83. Ault K. A., Rinder H. M., Mitchell J., Carmody M. B., Vary C. P., Hillman R. S. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol: 1992; 98 6 637 646
84. Gobbi G., Mirandola P., Carubbi C., et al. Phorbol ester-induced PKCepsilon down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation. Blood: 2009; 113 13 3080 3087
85. Gobbi G., Mirandola P., Carubbi C., et al. Proplatelet generation in the mouse requires PKCε-dependent RhoA inhibition. Blood: 2013; 122 7 1305 1311
86. Nurden P., Gobbi G., Nurden A., et al. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B. Blood: 2010; 115 13 2649 2656